Ambulkar R, Tan A Y H, Chia N C H, Low T C
Tata Memorial Centre, Parel, Mumbai 400012, India.
Singapore Med J. 2008 Jun;49(6):462-5.
The intubating laryngeal mask airway (ILMA) is a specially-designed airway device that can be used for endotracheal intubation without direct laryngoscopy. The advantage of this device is that it allows blind endotracheal intubation with a predictably high success rate. The use of neuromuscular blocking agents in facilitating the use of the ILMA has been investigated in the Western population with a quoted successful intubation rate of 88-96 percent. This randomised, double-blind study aimed to see if the use of neuromuscular blocking agent is necessary for successful intubations.
A total of 150 patients, rated categories 1 and 2 on the American Society of Anesthesiology Physical Status Classification System, were induced with propofol 2.5 mg/kg and fentanyl 2 microg/kg. After insertion of the ILMA, the patients received either saline or 0.6 mg/kg of rocuronium. After 90 seconds, tracheal intubation was attempted using the specially-designed silicon endotracheal tube. In addition to the success rate of intubation, the incidence of complications was also recorded.
The success rate for tracheal intubation within three attempts was 93.3 percent for the saline group and 92.0 percent for the rocuronium group; this was statistically insignificant. The time to securing the airway was 11.5 seconds for the saline group, compared to 10.0 seconds in the rocuronium group, but this was statistically insignificant. The incidence of coughing during insertion of the endotracheal tube was 42.7 percent in the saline group as compared to 1.3 percent in the rocuronium group (p-value is less than 0.001). 12 percent of the patients in the saline group moved during intubation, while none was reported to move in the rocuronium group (p-value is 0.003). These results compared favourably with rates quoted in studies conducted on Western populations.
The intubating laryngeal mask airway-assisted intubation yields a high success rate, which was similar between the paralysed and non-paralysed patients, with no statistical significance. However, the non-paralysed patients were prone to coughing and movements during intubation, requiring supplemental propofol.
气管插管型喉罩气道(ILMA)是一种专门设计的气道装置,可用于无需直接喉镜检查的气管插管。该装置的优点是能够在盲视下进行气管插管,且成功率较高。在西方人群中,已对使用神经肌肉阻滞剂辅助ILMA的情况进行了研究,报道的插管成功率为88%至96%。这项随机双盲研究旨在探讨成功插管是否需要使用神经肌肉阻滞剂。
总共150例美国麻醉医师协会身体状况分类系统评级为1级和2级的患者,静脉注射2.5mg/kg丙泊酚和2μg/kg芬太尼进行诱导麻醉。插入ILMA后,患者分别接受生理盐水或0.6mg/kg罗库溴铵。90秒后,使用特制的硅胶气管导管尝试进行气管插管。除记录插管成功率外,还记录并发症的发生率。
生理盐水组三次尝试内气管插管成功率为93.3%,罗库溴铵组为92.0%;差异无统计学意义。生理盐水组建立气道的时间为11.5秒,罗库溴铵组为10.0秒,但差异无统计学意义。气管导管插入过程中,生理盐水组咳嗽发生率为42.7%,罗库溴铵组为1.3%(p值小于0.001)。生理盐水组12%的患者在插管过程中出现肢体移动,而罗库溴铵组未报告有患者出现肢体移动(p值为0.003)。这些结果优于在西方人群中进行的研究报道的发生率。
气管插管型喉罩气道辅助插管成功率高,在使用神经肌肉阻滞剂的患者和未使用的患者中相似,无统计学差异。然而,未使用神经肌肉阻滞剂的患者在插管过程中容易咳嗽和肢体移动,需要追加丙泊酚。